Specialists

The most clinically validated solution
for Positional OSA

Clinical validation

Do you want more information on the SPT®?

Get to know the SPT®

Sleep Position Trainer

Comfortable & discrete therapy

 

The Sleep Position Trainer is a smart, wearable therapy that monitors you while you are asleep and gently vibrates to remind you to not sleep on your back, while preserving your natural sleep. It is so small that it fits in the palm of your hand, and is worn on the front side of the body in a comfortable, adjustable chest band.

What makes the SPT unique?

features01A-1features01A-1
features2features2
features3features3
features4features4
features6features6
features5features5
features7-1features7-1

For whom is the SPT® suitable?

Adults with Mild to Moderate OSA (AHI 5 to 30)

AHI supine > 2x AHI non-supine

AHI non-supine <10

Patient must be able to sleep in non-supine position

Broadcast from European Respiratory Society congress 2015 (English)

About Positional OSA

Obstructive Sleep Apnea (OSA) affects approximately 13% of men and 6% of women between the ages of 30 and 701. OSA is associated with excessive sleepiness, heavy snoring and an increased risk of developing heart and vascular disorders. It further reduces your quality of life 2,3. The gold standard treatment for severe OSA is Continuous Positive Airway Pressure (CPAP).

POSA=

AHI supine > 2x AHI non-supine

& AHI non-supine <5 4

POSA is highly prevalent in Mild and Moderate OSA

Prevalence of POSA expected to increase due to obesity crisis and aging population.

Guidelines about POSA therapy

  The Netherlands

OSA Guidelines

  1. Supine AHI > 2x AHI non-supine
  2. AHI between 5 and 30
  3. AHI non-supine <10
  4. % supine sleep time between 10% and 90% of total

  Germany

DGSM S3 Guidelines

  1. Mild to moderate position dependent OSA
    or
  2. Patient does not tolerate CPAP

  France

Recommandations pratique
du SAOS chez l’adulte

  1. POSA therapy is recommended for mild to moderate OSA in the absence of severe obesity and if clinical efficacy is controlled by sleep study
  2. For mild to moderate POSA in the absence of severe sleepiness (ESS score <15), POSA therapy is recommended

  United States

AASM OSA Guidelines

  1. Considered a second line therapy or supplement to primary therapy if low AHI in non-supine

Are you interested in prescribing the SPT®?

Please contact us for more information.

Already prescribing the SPT®?

Please share your experience with us.

Icon_Facebook
Icon_Twitter
Icon_Linkedin
Icon_Vimeo

References

  1. Paul E. Peppard et al., Increased prevalence of Sleep-Disordered breathing in Adults, 2013, American Journal of Epidemiology, vol 177 p 1006-1014.
  2. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31:1071-8.
  3. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O’Connor GT, Resnick HE, Diener-West M, Sanders MH, Wolf PA, Geraghty EM, Ali T, Lebowitz M, Punjabi NM (2010) Obstructive sleep apnea-hypopnea and incident of stroke: the sleep heart health study. Am J Respir Crit Care Med. 182:269-77.
  4. Mador et al (2006)
  5. Peppard et al (2013), Mador et al (2006), Richard et al (2006), Oksenberg et al (1997)